Related Experiment Videos
Antiproteinase 3- and antimyeloperoxidase-associated vasculitis
C F Franssen1, C A Stegeman, C G Kallenberg
1Department of Internal Medicine, Divisions of Nephrology and Clinical Immunology, University Hospital Groningen, Groningen, The Netherlands. c.f.m.franssen@int.azg.nl
Kidney International
|June 9, 2000
Summary
Antineutrophil cytoplasmic autoantibody-associated vasculitides differ based on the target antibody. Anti-proteinase 3 vasculitis often presents with more extrarenal disease and granulomas than anti-myeloperoxidase vasculitis.
Area of Science:
- Nephrology
- Rheumatology
- Immunology
Background:
- Wegener's granulomatosis, microscopic polyangiitis, and pauci-immune necrotizing crescentic glomerulonephritis are linked to antineutrophil cytoplasmic autoantibodies (ANCAs).
- ANCAs target either proteinase 3 (anti-PR3) or myeloperoxidase (anti-MPO), leading to the classification of ANCA-associated vasculitides.
- Distinct clinical and histopathologic features differentiate anti-PR3 and anti-MPO vasculitis.
Purpose of the Study:
- To review the clinical, histopathologic, and pathophysiologic differences between anti-PR3 and anti-MPO-associated vasculitis.
- To highlight characteristic findings that distinguish these two forms of vasculitis.
- To evaluate the utility of specific terminology in diagnosing and managing vasculitis.
Main Methods:
- Literature review focusing on comparative studies of anti-PR3 and anti-MPO vasculitis.
- Analysis of clinical presentation, organ involvement, and histopathological findings.
- Discussion of potential pathophysiologic distinctions.
Main Results:
- Anti-PR3 vasculitis is associated with more frequent extrarenal organ involvement and respiratory tract granulomas compared to anti-MPO vasculitis.
- Patients with anti-PR3-positive necrotizing crescentic glomerulonephritis often experience a more rapid decline in renal function.
- While overlap exists, specific clinical and histopathological patterns characterize each type.
Conclusions:
- Anti-PR3 and anti-MPO vasculitides represent distinct entities with characteristic clinical and histopathological differences.
- The terms 'ANCA-associated vasculitis,' 'anti-PR3-associated vasculitis,' and 'anti-MPO-associated vasculitis' are valuable for understanding and managing systemic vasculitis.